If mRNA technology could be shared with the listed companies, “we could vaccinate the world in as close to six months from now”

More than a dozen civil society groups in India have written an open urging Johnson & Johnson to cancel export of Indian-made COVID-19 vaccine doses to rich countries and instead focus on distributing them in the Global South

U.S. Backs Waiving COVID Vaccine Patent Rights After Months of Blocking Talks

We look at the urgent push to ensure equal access to COVID-19 vaccines for all nations, rich and poor, and growing calls for Big Pharma to waive their patent rights, as COVID-19 cases soar

Interview on Intellectual Property Laws around Drugs and Vaccines